Prevalence of XXXX in adults and neonates.

@entity1 @entity2954 @entity2756 @entity5517 @entity6368 @entity227 @entity1596 @entity2177 @entity6063
UNASSIGNED: PurposeTo report the prevalence of @entity2954 ( @entity2954 ) presenting to a tertiary referral maternity hospital (NMH) and a tertiary referral ophthalmic hospital (RVEEH) from 2011 to 2013 and describe the demographics, clinical presentation, and antibiotic susceptibility of @entity6368 @entity5517 .MethodsDemographic, clinical, and microbiological data were collected from @entity1 with laboratory confirmed @entity2954 .ResultsThere were 27   556 live births at NMH during the study period, and no case of neonatal @entity2954 was identified. Fourteen cases of @entity2954 were identified at RVEEH in this period, representing a prevalence of 0.19 cases per 1000 eye emergency attendees. Antibiotic susceptibility data were available on nine cases, of which, all were @entity2756 - and @entity2177 sensitive. 64.3% of @entity1 were male, with a mean age of 18 years. The mean duration of symptoms was 3 days. All @entity1 presented with unilateral conjunctival injection and purulent discharge. Eight cases had @entity227 at presentation and their mean visual acuity was 6/15. Corneal involvement was present in 25% of @entity1 . @entity1596 was not detected. On receipt of positive culture and/or PCR results, treatment was altered in two thirds of @entity1 . All @entity1 were referred for full STI screening and all @entity1 showed a full clinical recovery 1 week posttreatment.ConclusionWe observed that @entity2954 presented in young adults with a male predominance and was rare in neonates. In cases of unilateral @entity6063 , there should be a high clinical suspicion of @entity2954 , early swab for PCR and culture, and knowledge of current CDC-recommended antibiotic guidelines.Eye advance online publication, 24 April 2015; doi:10.1038/eye.2015.57.
